Kommentar
Deprescribing Proton Pump Inhibitors and the Challenge of Legacy Medications
JAMA Internal Medicine · 01.06.2026 · 186 (6) · 656
DOI: 10.1001/jamainternmed.2026.0594 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Internal Medicine, erschienen am 01.06.2026. Verfasst von Timothy S Anderson. Beteiligte Einrichtung: Division of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
- Center for Healthcare Evaluation, Research, and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania.
- Associate Editor, JAMA Internal Medicine.
Zitieren
APA
Anderson, T. S. (2026). Deprescribing Proton Pump Inhibitors and the Challenge of Legacy Medications. JAMA Internal Medicine, 186(6), 656. https://doi.org/10.1001/jamainternmed.2026.0594
Vancouver
Anderson TS. Deprescribing Proton Pump Inhibitors and the Challenge of Legacy Medications. JAMA Internal Medicine. 2026;186(6):656. doi:10.1001/jamainternmed.2026.0594
BibTeX
@article{Anderson2026,
author = {Anderson, Timothy S},
title = {Deprescribing Proton Pump Inhibitors and the Challenge of Legacy Medications},
journal = {JAMA Internal Medicine},
year = {2026},
volume = {186},
number = {6},
pages = {656},
doi = {10.1001/jamainternmed.2026.0594}
}
EUVIMED